Vaccination against hepatitis A in children: A review of the evidence

References

• BellBPFeinstoneSMPlotkinSAOrensteinWAHepatitis A VaccineVaccines20044PhiladelphiaSaunders26997
   Google Scholar
• BonanniPImplementation in Italy of a universal vaccination programme against hepatitis BVaccine199513Suppl 1S68S717571837
   PubMed Web of Science ®Google Scholar
• BonanniPColombaiRFranchiGExperience of hepatitis A vaccination during an outbreak in a nursery school of Tuscany, ItalyEpidemiol Infect1998121377809825788
   PubMed Web of Science ®Google Scholar
• BonanniPFranzinAStaderiniCVaccination against hepatitis A during outbreaks starting in schools: what can we learn from experiences in central Italy?Vaccine20052321768015755590
   PubMed Web of Science ®Google Scholar
• [CDC] Centers of Disease ControlPrevention of hepatitis A through active or passive immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP)MMWR199948RR-12
   Google Scholar
• [CDC] Centers of Disease ControlRecommended childhood and adolescent immunization schedule – United States, 2006MMWR200654N. 51–52
   Google Scholar
• ChanCYLeeSDYuMILong-term follow-up of hepatitis A vaccination in childrenVaccine199917369729987176
   PubMed Web of Science ®Google Scholar
• ConnorBAHepatitis A vaccine in the last-minute travelerAm J Med200511858S62S16271543
   PubMed Web of Science ®Google Scholar
• CrovariPIcardiGCCalcagnoPImmunogenicity and safety of an inactivated hepatitis A vaccine in young adultsJ Prev Med Hyg19923311115
   Google Scholar
• DaganRAmirJMijalovskyAImmunization against hepatitis A in the first year of life: priming despite the presence of maternal antibodyPediatr Infect Dis J20001910455211099084
   PubMed Web of Science ®Google Scholar
• DaganRLeventhalAAnisEIncidence of hepatitis A in Israel following universal immunization of toddlersJAMA20052942021016014594
   PubMed Web of Science ®Google Scholar
• FanPCChangMHLeePIFollow-up immunogenicity of an inactivated hepatitis A virus vaccine in healthy children: results after 5 yearsVaccine19981623259607035
   PubMed Web of Science ®Google Scholar
• FioreAEShapiroCSabinKMPersistence of protective antibody concentrations and response to a booster among children given hepatitis A vaccine during infancy: effect of maternal antibody2001378Proceedings of the 39th Annual Meeting of the Infectious Diseases Society of America (IDSA)Oct 25–28, 2001San Francisco, USASan FranciscoInfectious Diseases Society of America
   Google Scholar
• InnisBLSnitbhanRKunasolPProtection against hepatitis A by an inactivated vaccineJAMA19942711328348158817
   PubMed Web of Science ®Google Scholar
• LopalcoPLMalfaitPMenniti-IppolitoFDeterminants of acquiring hepatitis A virus disease in a large Italian region in endemic and epidemic periodsJ Viral Hepat2005123152115850473
   PubMed Web of Science ®Google Scholar
• LopalcoPLSallerasLBarbutiSHepatitis A and B in children and adolescents – what can we learn from Puglia (Italy) and Catalonia (Spain)?Vaccine200019470411027810
   PubMed Web of Science ®Google Scholar
• MalfaitPLopalcoPLSalmasoSAn outbreak of hepatitis A in Puglia, Italy, 1996Eurosurveillance19961333512631838
   PubMedGoogle Scholar
• MaoJSChaiSAXieRYFurther evaluation of the safety and protective efficacy of live attenuated hepatitis A vaccine (H2-strain) in humansVaccine1997594479261939
   PubMed Web of Science ®Google Scholar
• McMahonBJBellerMWilliamsJA program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccineArch Pediatr Adolesc Med199615073398673200
   PubMed Web of Science ®Google Scholar
• NalinDRKuterBJBrownLWorldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adults populations: an overviewJ Hepatol199318suppl 2S5158182275
   PubMed Web of Science ®Google Scholar
• PiazzaMSafaryAVegnenteASafety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programmeVaccine199917585810075165
   PubMed Web of Science ®Google Scholar
• PolandGAEvaluating existing recommendations for hepatitis A and B vaccinationAm J Med200511810A16S20S16271536
   PubMed Web of Science ®Google Scholar
• PrikazskyVOlearVCernochAInterruption of an outbreak of hepatitis A in two villages by vaccinationJ Med Virol19944445797897381
   PubMed Web of Science ®Google Scholar
• PurcellRHD’HondtEBradburyRInactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzeesVaccine199210suppl14851
   Web of Science ®Google Scholar
• SaglioccaLAmorosoPStroffoliniTEfficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomised trialLancet19993531136910209977
   PubMed Web of Science ®Google Scholar
• ShawFESudmanJHSmithSMA community-wide epidemic of hepatitis A in OhioAm J Epidem1986123105765
   PubMed Web of Science ®Google Scholar
• Van DammePMatheiCThoelenSSingle dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicityJ Med Virol199444435417897376
   PubMed Web of Science ®Google Scholar
• Van DammePBanatvalaJFayOHepatitis A booster vaccination: is there a need?Lancet200336210657114522539
   PubMed Web of Science ®Google Scholar
• van GorkomJLeentvaar-KuijpersAKoolJLAnnual epidemics of hepatitis A in four large cities related to holiday travel among immigrant childrenNed Tijdschr Geneeskd19981421919239856179
   PubMedGoogle Scholar
• WasleyASamandariTBellBPIncidence of hepatitis A in the United States in the era of vaccinationJAMA200529419420116014593
   PubMed Web of Science ®Google Scholar
• WerzbergerAMenschBKuterBA controlled trial of a formalin-inactivated hepatitis A vaccine in healthy childrenN Engl J Med199232745371320740
   PubMed Web of Science ®Google Scholar
• WerzbergerAKuterBShouvalDAnatomy of a trial: a historical view of the Monroe inactivated hepatitis A protective efficacy trialJ Hepatol199318Suppl 2S46S508182273
   PubMed Web of Science ®Google Scholar
• WerzbergerAKuterBNalinDSix years’ follow-up after hepatitis A vaccinationN Engl J Med199833811609547152
   PubMed Web of Science ®Google Scholar
• WerzbergerAMenschBNalinDREffectiveness of hepatitis A vaccine in a former frequently affected community: 9 years’ followup after the Monroe field trial of VAQTAVaccine200220169970111906754
   PubMed Web of Science ®Google Scholar
• [WHO] World Health OrganizationPublic health control of hepatitis A: memorandum from a WHO meetingBull WHO19957315207704922
   PubMed Web of Science ®Google Scholar
• [WHO] World Health OrganizationWHO position paper on hepatitis A vaccinesWkly Epidemiol Rec200075384410693358
   PubMedGoogle Scholar
• WiensBLBohidarNRPigeonJGDuration of protection from clinical hepatitis A disease after vaccination with VAQTAJ Med Virol199649235418818971
   PubMed Web of Science ®Google Scholar
• WilliamsJBrudenDMcMahonBResponse to two doses of hepatitis A vaccine administered an average of 27 months apartAntiviral Ther2000135
   Google Scholar